6 completed, 1 unknown. 4 Phase 2, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow Recurrent Herpes Labialis: new trials by email Literature Review of Recurrent Herpes Labialis trials Research Report on Recurrent Herpes Labialis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773, Placebo - Recurrent Herpes Labialis | Phase 3 | Completed | Bayer | 2020 | 2021-11-23 | 2025-09-02 |
| An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis BOR15001L7, Docosanol Cream 10% - Recurrent Herpes Labialis | Phase 2 | Unknown | Laboratoire Boreaderme Inc. | 164 | 2020-09-01 | 2020-09-07 |
| Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for Episodic Treatment of Cold Sores Merlin, Ethanol - Recurrent Herpes Labialis | Phase 2 | Completed | Topical Remedy | 451 | 2017-07-05 | 2018-09-12 |
| Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores ethanol/glycolic acid solution, Placebo/Ethanol - Recurrent Herpes Labialis | Phase 2 | Completed | Topical Remedy | 469 | 2013-11-01 | 2015-07-16 |
| A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS) NB-001, Vehicle - Recurrent Herpes Labialis | Phase 3 | Completed | NanoBio Corporation | 847 | 2011-04-01 | 2013-05-23 |
| Place Controlled Study to Treat Recurrent Herpes Labialis. Ointment - Recurrent Herpes Labialis | Phase 2 | Completed | University of Zurich | 40 | 2009-04-01 | 2011-08-08 |
| A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis Famciclovir - Recurrent Herpes Labialis | Phase 4 | Completed | Novartis | 2003-10-01 | 2007-12-10 |
Herpes Labialis (7) · Herpes Simplex (1) · Herpesviridae Infections (1) · Skin Diseases, Infectious (1)
DNA Virus Infections (7) · Infections (7) · Lip Diseases (7) · Mouth Diseases (7) · Skin Diseases (7) · Skin Diseases, Viral (7) · Skin and Connective Tissue Diseases (7) · Stomatognathic Diseases (7) · Virus Diseases (7) · Herpes Simplex (6) · Herpesviridae Infections (6) · Skin Diseases, Infectious (6)
Ethanol (2) · Neurofibromin 2 (2) · 5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol (1) · Acyclovir (1) · Famciclovir (1) · Ointments (1) · Tablets (1)
Topical Remedy (2) · Bayer (1) · Laboratoire Boreaderme Inc. (1) · NanoBio Corporation (1) · Novartis (1) · University of Zurich (1)
United States (4) · Switzerland (1)
Daniel H Brune, MD (1) · Murray A Kimmel, DO (1) · Patrick Yassini, MD (1) · Randle T Middleton, MD (1) · Stephen A Bart, Sr., M.D. (1) · Stephen Daniels, DO (1)